Lupin informs about press release

15 Feb 2024 Evaluate
Lupin has enclosed a Press Release regarrding, launch of Ganirelix Acetate Injection, 250 mcg/0.5 mL, Single-Dose Prefilled Syringe, after having received an approval from the US FDA. This is considered as a disclosure pursuant to Regulation 30 of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2170.70 -19.05 (-0.87%)
13-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.80
Dr. Reddys Lab 1190.35
Cipla 1448.15
Zydus Lifesciences 899.25
Lupin 2170.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×